Imexhs Ltd · ASX:IME
Imexhs — Shareholder Meeting (May 2021)
34 slides from Imexhs's shareholder meeting presentation, May 13, 2021
Slide 1: Annual General Meeting
For personal use only Built by physicians for physicians Annual General Meeting 13 May 2021 1
Slide 2: Board of Directors
Board of Directors For personal use only Doug Flynn Carlos Palacio Dr Doug Lingard Damian Banks Dr German Arango Non-Executive Non-Executive Non-Executive Non-Executive CEO and Managing Chairman Director Director Director Director 2
Slide 3: Registration and Voting
Registration and Voting For personal use only 1. Log in or register at: 2. Click view and register 3. Record your vote. Once https://investor.automic.com.au/#/home your attendance for the you confirm it is lodged meeting and final To contact support: Call 1300 816 159 or open live chat from the Inve
Slide 4: Chairman’s Address
For personal use only Chairman’s Address Doug Flynn 4
Slide 5: Innovative provider of cloud-based medical imaging software solutions
For personal use only Innovative provider of cloud-based medical imaging software solutions IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021 5
Slide 6: CEO’s Address
For personal use only CEO’s Address Dr German Arango 6
Slide 7: Our purpose and value proposition
Democratise access to high tech imaging management platforms with advanced OUR PURPOSE clinical applications, user-friendly software and AI For personal use only OUR VALUE PROPOSITION Modern platform Patient-centric Clinical Analytics • Reduce IT • Regional image collaboration • Multi-departmental i
Slide 8: Expanding global footprint
Expanding global footprint For personal use only Spain 15 countries USA >270 sites Mexico Honduras >2,100 radiologists El Salvador Nicaragua Australia Costa Rica Colombia 25 distributors Panama Ecuador Peru Brazil Bolivia +95% Paraguay customer retention Chile Uruguay IMEXHS currently operating 1/3
Slide 9: Leading innovator in medical imaging
Leading innovator in medical imaging For personal use only • Multi-tenant architecture, cloud- • HIRUKOTM platform provides based medical imaging software solutions for all complexity levels • Subscription model with high • Aquila in the Cloud standardised recurring revenue from multi-year radiology
Slide 10: Multiple runways for growth
Multiple runways for growth For personal use only Aquila Custom Aquila in the Cloud Other Medical Verticals • Aquila customised • Standardised • Alula – pathology radiology offering radiology solution • Anteros – cardiology • 5-year contracts on • 1-2 year contracts on average average • Extend into
Slide 11: HIRUKO medical imaging platform
HIRUKOTM medical imaging platform For personal use only Advanced Stella Vital Alma Braviz Post-processing AI 3D ADv 3D Basic Enterprise Aquila Alula Anteros Imaging Radiology Pathology Cardiology Core Platform HIRUKOTM Universal Portals Multi-Tenancy PACS/VNA Viewer Nuance 360 IMEXHS LTD (ASX:IME) |
Slide 12: End-to-end modular imaging solution
For personal use only End-to-end modular imaging solution Scan scheduled via our platform Uploaded to our platform Archived on our cloud-based platform Manages Billing } 1)Business Intelligence 2)Statistical Data 3. 4. 5. 1. 2. Radiologist Referring Physician Billing Physician Patient has interprets
Slide 13: Aquila in the Cloud
Aquila in the Cloud For personal use only • Standardised radiology solution launched in May $1,300k 2020 • Provides small and medium-sized customers 60 with low-cost, rapidly deployed product offering $945k • At 31 March 2021, 60 deals signed with ARR $675k 41 contribution of $1.3m $473k • 3 deals i
Slide 14: Range of solutions for AiC customers
Range of solutions for AiC customers For personal use only LITE PRO ULTIMATE Multiplatform Unlimited Users Unlimited Exams 100% Web Platform Modality Worklist Scheduling Management VNA | PACS Archiving SMS notifications Digital Signature in Reports Web Viewer Patient Admission VR Web (Reporting) (*)
Slide 15: Multiple distribution channels
Multiple distribution channels For personal use only • Distributors partners represent important • New distribution channel on Ingram’s Micro sales channel for both Aquila Custom and Cloud marketplace Aquila in the Cloud DISTRIBUTION CHANNELS DIRECT SALES DISTRIBUTORS • Several markets • Agreements
Slide 16: Developing AI capabilities
Developing AI capabilities For personal use only Number of Images Stored (m) • Images almost doubled to 940m reflecting 940 full year of Colsubsidio contract • Important test bed for the development and training of AI tools 488 • Developed Stella AI which identifies normal and pathological radiologi
Slide 17: FY20 Financial Highlights
FY20 Financial Highlights For personal use only Sales Revenue of ARR of EBITDA of $10.9m $10.1m ($1.3m) Up 41% yoy1, new contract Up 19% yoy, 33% higher on a Improvement of $3.3m, wins & renewals constant currency basis $2.5m on like for like basis3 Recurring revenue of Underlying EBITDA4 of Closing
Slide 18: Strong growth in ARR
Strong growth in ARR For personal use only Annualised Recurring Revenue 20162017201820192020 Mar-21 • Q1 FY21 Annual Recurring Revenue 12 (ARR) of $11.0m (Q1 FY20: $9.2m) 10 • 19 AiC contract wins in Q1 FY21 8 including two in USA and one in A$ Millions Australia 6 4 • AQUILA Radiology Information S
Slide 19: Q1 FY21 Financial Highlights
Q1 FY21 Financial Highlights For personal use only Sales revenue1 of ARR of $2.5m $11.0m Up 9% pcp, Up 19% pcp, up 17% on a constant currency basis up 29% on a constant currency basis Recurring revenue1 of Closing cash of $2.2m $10.3m Up 7% pcp, $10.8m at 31 Dec 2020 up 15% on a constant currency ba
Slide 20: 2021 Product Roadmap
2021 Product Roadmap For personal use only AQUILA 4.0 with new Alula Marketplace, the Other medical verticals AI Algorithms features and functions world’s first dedicated • Dental Imaging • Automatic detection and orientated to US and pathology marketplace platform segmentation of Australian markets
Slide 21: 2021 Outlook
2021 Outlook For personal use only Strong near-term pipeline for larger US – build presence with AiC offering customised solutions and via online marketplaces Aquila in the Cloud (AiC) – strong underlying demand as optimise pre- New markets – delay in Brazil due to installation activities COVID-19 P
Slide 22: 2021 Annual General Meeting: Business of Meeting
For personal use only Built by physicians for physicians 2021 Annual General Meeting BUSINESS OF MEETING 22
Slide 23: 2020 Financial Statement and Reports
For personal use only 2020 Financial Statement and Reports To receive the financial report of the Company and the reports of the Directors and of the Auditors for the financial year ended 31 December 2020. IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021 23
Slide 24: Resolution 1: Remuneration Report
For personal use only RESOLUTION 1: Remuneration Report “The Remuneration Report for the financial year ended 31 December 2020 as disclosed in the Company’s Annual Report be adopted.” FOR AGAINST OPEN 6,842,254 1 152,208 97.82% 0% 2.18% IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021 24
Slide 25: Resolution 2: Re-election of Director – Mr Damian Banks
For personal use only RESOLUTION 2: Re-election of Director – Mr Damian Banks “That, for the purpose of Article 6.3(j) of the Constitution, ASX Listing Rule 14.4 and for all other purposes, Mr Damian Banks, a Director having been appointed by the Board, retires, and being eligible, is re-elected as
Slide 26: Resolution 3: Re-election of Director – Dr Douglas Lingard
For personal use only RESOLUTION 3: Re-election of Director – Dr Douglas Lingard “That, for the purpose of Article 6.3(c) of the Constitution, ASX Listing Rule 14.4, and for all other purposes, Dr Douglas Lingard, a Director, retires by rotation, and being eligible, is re-elected as a Director of th
Slide 27: Resolution 4: Grant of Options to the Chief Executive Officer
For personal use only RESOLUTION 4: Grant of Options to the Chief Executive Officer “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 43,519 Options to the Managing Director & CEO, Dr German Arango, under the Plan on the terms and conditi
Slide 28: Resolution 5: Grant of Options to Mr Damian Banks
For personal use only RESOLUTION 5: Grant of Options to Non-Executive Director, Mr Damian Banks “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 19,719 Options to Non-Executive Director, Mr Damian Banks, under the Plan on the terms and c
Slide 29: Resolution 6: Grant of Options to Mr Douglas Flynn
For personal use only RESOLUTION 6: Grant of Options to Non-Executive Director, Mr Douglas Flynn “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 39,437 Options to Non-Executive Director, Mr Douglas Flynn, under the Plan on the terms and
Slide 30: Resolution 7: Grant of Options to Dr Douglas Lingard
For personal use only RESOLUTION 7: Grant of Options to Non-Executive Director, Dr Douglas Lingard “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 19,719 Options to Non-Executive Director, Dr Doug Lingard, under the Plan on the terms an
Slide 31: Resolution 8: Grant of Options to Mr Carlos Palacio
For personal use only RESOLUTION 8: Grant of Options to Non-Executive Director, Mr Carlos Palacio “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 19,719 Options to Non-Executive Director, Mr Carlos Palacio, under the Plan on the terms a
Slide 32: Resolution 9: Approval of 10% Share Placement Capacity
For personal use only RESOLUTION 9: Approval of 10% Share Placement Capacity "That, for the purposes of ASX Listing Rule 7.1A and for all other purposes, Shareholders approve the Company having additional capacity to issue Equity Securities up to 10% of the issued capital of the Company (at the time
Slide 33: Resolution 10: Ratification of Prior Issue of Securities (Placement)
For personal use only RESOLUTION 10: Ratification of Prior Issue of Securities (Placement) “That, for the purposes of ASX Listing Rule 7.4 and for all other purposes, the Shareholders ratify the issue on 30 October 2020 of a total of 276,000,000 fully paid ordinary shares in the Company at an issue
Slide 34: Disclaimer
Disclaimer For personal use only The information contained in this Presentation or subsequently provided to the Recipient of this Presentation, whether orally or in writing by or on behalf of ImExHS Limited or its respective employees, agents or consultants (“Information”) is provided to the Recipie